Trade Amarin Corporation plc - AMRN CFD

Add to favourite

0.4024

1.39%

0.0098

Low: 0.3882

High: 0.4143

Market Trading Hours* (UTC) Open now
Closes on Monday at 20:00

Mon - Fri: 13:30 - 20:00

Summary
Historical Data

Trading сonditions

Spread

0.0098

Long position overnight fee

-0.023624%

Short position overnight fee

0.001401%

Overnight fee time

21:00 (UTC)

Min traded quantity

Currency

USD

Margin

5.00%

Stock exchange

United States of America

Commission on trade

Key Stats

Prev. Close	0.3969
Open	0.3912
1-Year Change	-61.55%
Day's Range	0.3882 - 0.4143

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Apr 4, 2025	0.3965	-0.0194	-4.66%	0.4159	0.4162	0.3849
Apr 3, 2025	0.4181	0.0046	1.11%	0.4135	0.4471	0.4100
Apr 2, 2025	0.4285	-0.0020	-0.46%	0.4305	0.4446	0.4157
Apr 1, 2025	0.4321	-0.0117	-2.64%	0.4438	0.4585	0.4285
Mar 31, 2025	0.4455	0.0197	4.63%	0.4258	0.4468	0.4186
Mar 28, 2025	0.4352	-0.0133	-2.97%	0.4485	0.4562	0.4210
Mar 27, 2025	0.4599	0.0181	4.10%	0.4418	0.4652	0.4331
Mar 26, 2025	0.4539	-0.0038	-0.83%	0.4577	0.4596	0.4386
Mar 25, 2025	0.4471	-0.0146	-3.16%	0.4617	0.4726	0.4466
Mar 24, 2025	0.4629	0.0044	0.96%	0.4585	0.4778	0.4539
Mar 21, 2025	0.4511	0.0126	2.87%	0.4385	0.4653	0.4243
Mar 20, 2025	0.4341	-0.0108	-2.43%	0.4449	0.4628	0.4230
Mar 19, 2025	0.4628	0.0338	7.88%	0.4290	0.4885	0.4229
Mar 18, 2025	0.4295	0.0126	3.02%	0.4169	0.4313	0.3975
Mar 17, 2025	0.4038	-0.0008	-0.20%	0.4046	0.4194	0.3793
Mar 14, 2025	0.4046	-0.0055	-1.34%	0.4101	0.4218	0.3901
Mar 13, 2025	0.4033	-0.0038	-0.93%	0.4071	0.4219	0.3785
Mar 12, 2025	0.3885	-0.0149	-3.69%	0.4034	0.4458	0.3470
Mar 11, 2025	0.4637	-0.0048	-1.02%	0.4685	0.4777	0.3974
Mar 10, 2025	0.4549	-0.0636	-12.27%	0.5185	0.5269	0.3939

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

1:1
2:1
3:1
5:1
10:1
20:1

Leverage

20:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Amarin Corporation plc Company profile

Amarin Corporation (AMRN) is a clinical-stage biopharmaceutical company focused on the commercialisation and improvement of therapeutics to cure and deal with cardiovascular diseases.

Established in 1989, Amarin is headquartered in Dublin, Ireland, and operates in several European countries, the United States, Canada, Lebanon and the United Arab Emirates.

The company’s lead commercial product VASCEPA (icosapent ethyl) is a prescription-only omega-3 fatty acid product. Taken as an adjunct to diet, it reduces triglyceride levels in adult patients suffering from severe hypertriglyceridemia. The drug helps to address cardiovascular risk for millions of patients.

VASCEPA was launched in the United States in 2013, but gained wider recognition in 2019 as the US Food and Drug Administration (FDA) approved Amarin for a broader indication for cardiovascular risk reduction in studied high-risk patients. It has also got approval from the European Commission to reduce the risks for cardiac patients.

Amarin still prices VASCEPA at a considerably lower level than other new drugs of its category.

Formerly known as Ethical Holdings, the company changed its name to Amarin Corporation in 1999. The company went public in July 2019. It trades on the Nasdaq under the ticker ‘AMRN’.

Industry:

Bio Therapeutic Drugs

First Floor, Block 3, The Oval,
Shelbourne Road, Ballsbridge
DUBLIN
IE